“The Delta variant is well on its way to becoming the dominant variant globally because of its increased transmissibility,” Swaminathan told a news conference.

Several European Union member states have stopped administering the AstraZeneca vaccine to people below a certain age, usually ranging from 50 to 65, restricting its use to older people, due to very rare cases of blood clotting, mainly among young people.